UBS lifts target to USD 1,200 for McKesson stock

Published on 10/26/2026 at 16:34 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

UBS set a USD 1,200 target on October 16, 2026. McKesson stock costs EUR 894.30 at Lang & Schwarz on October 26, 2026 in trading.

Analyst target and earnings

UBS raised its McKesson target from USD 1,080.00 to USD 1,200.00 on October 16, 2026.
McKesson reported fiscal 2027 first-quarter revenue of USD 105.38 billion, up 7.70 percent year over year.
McKesson stock costs EUR 894.30 at Lang & Schwarz on October 26, 2026 at 4:31 p.m. CEST.

McKesson, US58155Q1031, Illustration mit AI erstellt.

McKesson stock (ISIN US58155Q1031) is trading at EUR 894.30 at Lang & Schwarz on October 26, 2026 at 4:31 p.m. CEST. UBS raised its price target from USD 1,080.00 to USD 1,200.00 on October 16, 2026, while keeping a Buy rating, as reported by Markets Insider.

UBS target reaches USD 1,200

The UBS move is the strongest recent analyst revision identified for McKesson. Its USD 1,200.00 target is USD 120.00 above the USD 1,080.00 level previously cited by the firm. The report retained the Buy rating and dated the change to October 16, 2026.

Another recent revision came from Mizuho. MarketBeat reported on October 20, 2026 that Mizuho lifted its target from USD 905.00 to USD 1,020.00 while maintaining a Neutral rating.

Revenue reached USD 105.38 billion

McKesson reported fiscal 2027 first-quarter revenue of USD 105.38 billion, up 7.70 percent from the same period a year earlier. Quarterly earnings per share came to USD 9.93, exceeding the USD 9.56 consensus estimate by USD 0.37, according to MarketBeat.

McKesson trades below its yearly high

The US-listed stock was quoted at USD 997.70 on the NYSE at 11:33 a.m. ET on October 26, 2026. Its USD 723.68 to USD 1,030.27 52-week range places the latest US quote USD 32.57 below the high. Market capitalization stood at USD 116.3 billion, with a price-to-earnings ratio of 26.70 and volume of 141,388 shares.

Comparison with peers

McKesson: minus 0.31 percent, P/E 26.70, market capitalization USD 116.3 billion.

Cencora (NYSE, USD): plus 0.71 percent, P/E 24.77, market capitalization USD 63.6 billion.

Cardinal Health (NYSE, USD): plus 1.40 percent, P/E 35.05, market capitalization USD 58.6 billion.

Healthcare distribution remains central

McKesson describes itself as a healthcare services company supporting medicine distribution, pharmacy services, oncology and specialty care. Its corporate profile lists approximately 43,000 employees worldwide and operations across the United States and Canada.

Stock price in euros

The McKesson quote was EUR 894.30 at Lang & Schwarz on October 26, 2026 at 4:31 p.m. CEST. The further course of trading is shown by the continuously updated real-time quote of McKesson stock.